Skip to main content
HairCited

Minoxidil untuk Alopecia Areata

A

Berdasarkan 48 studi (2 meta-analyses, 1 RCT) dengan 21,842 peserta secara total. 37/48 studi menunjukkan efek positif.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dalopecia\u002Dareata'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Kesimpulan

Minoxidil has strong evidence supporting its use for alopecia areata, with the majority of studies showing positive effects, and is widely used as both a topical and oral option for this condition.

  • 37 out of 48 studies show positive effects across a large pool of 21,842 participants
  • Available in topical (2% and 5%) and oral low-dose formulations
  • Extends the hair growth phase and increases blood supply to hair follicles
  • Often used in combination with other treatments like corticosteroids for enhanced effectiveness

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None Efek: None None

Populasi: women with androgenetic alopecia (female pattern hair loss)

Case Reports n=1
Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case …
Dose: None vs: None Outcome: hair regrowth in severe alopecia areata Efek: None None

Populasi: patient with severe alopecia areata with suboptimal response to tofacitinib

review
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.
Dose: Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 vs: Placebo Efek: Comparable efficacy to topical minoxidil; hypertrichosis 24%, shedding 16-22%, peripheral edema 2% None
Review
Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities.
Dose: None vs: None Outcome: None Efek: None None

Populasi: None

review
The Use of Light-Based Therapies in the Treatment of Alopecia.
Dose: Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri vs: Placebo Efek: LLLT improves hair density in AGA; potential to prolong anagen phase in telogen effluvium; may promo None
retrospective cohort study n=321
Asynchronous Teledermatology for Non-Scarring Alopecia: A Retrospective Study.
Dose: Minoxidil (OTC) and clobetasol for mild cases; prescription medications for moderate-severe. Specifi vs: Placebo Efek: 91.3% received definitive remote diagnosis; only 8.7% required in-person follow-up. AA most common ( None

Key Statistics

122

Studi

27416

Peserta

Positive

A

Peringkat

Referenced Papers

Dermatologic clinics 2025 5 sitasi
Pediatric dermatology 2025 5 sitasi
Journal of the … 2025 2 sitasi
International journal of … 2025 1 sitasi
Journal of clinical … 2025 1 sitasi
Archives of dermatological … 2025
International journal of … 2024 39 sitasi
American family physician 2024 8 sitasi
Skin health and … 2024 7 sitasi
Archives of dermatological … 2023 16 sitasi
The Cochrane database … 2023 2 sitasi
The Journal of … 2022 170 sitasi
Journal of the … 2022 90 sitasi
Skin appendage disorders 2022 7 sitasi
Journal of dermatological … 2021 51 sitasi
American journal of … 2020 127 sitasi
International journal of … 2020 58 sitasi
The journal of … 2020 3 sitasi
The Australasian journal … 2019 152 sitasi
American journal of … 2019 84 sitasi
Expert opinion on … 2019 34 sitasi
Klinicka onkologie : … 2019 11 sitasi
Journal of the … 2018 114 sitasi
Dermatology online journal 2018
American family physician 2017 141 sitasi
American journal of … 2017 32 sitasi
Actas dermo-sifiliograficas 2017 17 sitasi
Deutsches Arzteblatt international 2016 99 sitasi
Current problems in … 2015 322 sitasi
Canadian family physician … 2015 31 sitasi
The journal of … 2015 25 sitasi
Current problems in … 2015 18 sitasi
Der Internist 2015
American journal of … 2014 82 sitasi
Expert opinion on … 2014 57 sitasi
Giornale italiano di … 2014 18 sitasi
Giornale italiano di … 2014
International journal of … 2013 61 sitasi
Recent patents on … 2011 6 sitasi
Seminars in cutaneous … 2009 85 sitasi
American family physician 2009
The Cochrane database … 2008 222 sitasi
Current opinion in … 2008 31 sitasi
International journal of … 2007 185 sitasi
Alopecia areata. Case Report
Dermatology nursing 2007
The Australasian journal … 2006
Journal of the … 2005 44 sitasi
Cleveland Clinic journal … 2005
Praxis 2003 28 sitasi
American family physician 2003 2 sitasi
American family physician 2003
American journal of … 2000 28 sitasi
International journal of … 1999 16 sitasi
Dermatologic clinics 1998 121 sitasi
American family physician 1990
Dermatologic clinics 1987
Journal of the … 1984 122 sitasi
Journal of the … 1984
Archives of dermatology 1984

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosis yang Umum Digunakan

topical:
2-5% solution, twice daily

Batas atas: 5% topical solution

Dosis yang Diteliti dalam Penelitian

Dosis Durasi Efek N
None -- Neutral --
None -- Positive 1
Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 -- Positive --
None -- Mixed --
Low-level light therapy (LLLT) various devices and wavelengths; combined with minoxidil or finasteri -- Positive --
Minoxidil (OTC) and clobetasol for mild cases; prescription medications for moderate-severe. Specifi -- Positive 321
None -- Mixed --
None -- Mixed 1

Waktu terbaik diminum: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

Efek Samping yang Dilaporkan

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

Interaksi yang Diketahui

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

Asupan atas yang dapat ditoleransi: 5% topical solution

Selalu konsultasikan dengan tenaga kesehatan Anda sebelum memulai suplemen apa pun.Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai suplemen apa pun.

Frequently Asked Questions

Does Minoxidil help with Alopecia Areata?
Based on 122 studies with 27,416 participants, there is strong evidence from multiple clinical trials that Minoxidil may support Alopecia Areata management. Our evidence grade is A (Strong Evidence).
How much Minoxidil should I take for Alopecia Areata?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Minoxidil?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Minoxidil and Alopecia Areata?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 122 peer-reviewed studies with 27,416 total participants. The overall direction of effect is positive.

Related Evidence

Penafian FDA: Pernyataan-pernyataan ini belum dievaluasi oleh Food and Drug Administration. Produk dan informasi di situs web ini tidak dimaksudkan untuk mendiagnosis, mengobati, menyembuhkan, atau mencegah penyakit apa pun. Peringkat bukti yang disajikan didasarkan pada analisis kami terhadap penelitian yang ditinjau sejawat dan tidak merupakan saran medis. Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai regimen suplemen apa pun.